257 related articles for article (PubMed ID: 12168816)
1. Mistletoe extracts standardized to mistletoe lectins in oncology: review on current status of preclinical research.
Mengs U; Göthel D; Leng-Peschlow E
Anticancer Res; 2002; 22(3):1399-407. PubMed ID: 12168816
[TBL] [Abstract][Full Text] [Related]
2. [Value of mistletoe lectin standardized mistletoe extract for evaluating antitumor properties].
Mengs U; Witthohn K; Schwarz T; Lentzen H
Wien Med Wochenschr; 1999; 149(8-10):262-4. PubMed ID: 10483695
[TBL] [Abstract][Full Text] [Related]
3. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
Kelter G; Schierholz JM; Fischer IU; Fiebig HH
Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
[TBL] [Abstract][Full Text] [Related]
5. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Bocci V
J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
[TBL] [Abstract][Full Text] [Related]
6. Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins.
Büssing A; Schietzel M
Anticancer Res; 1999; 19(1A):23-8. PubMed ID: 10226520
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).
Janssen O; Scheffler A; Kabelitz D
Arzneimittelforschung; 1993 Nov; 43(11):1221-7. PubMed ID: 8292069
[TBL] [Abstract][Full Text] [Related]
8. A new gene encoding the ribosome-inactivating protein from mistletoe extracts.
Tonevitsky AG; Agapov II; Pevzner IB; Maluchenko NV; Moisenovich MM; Palmer RA; Yurkova M; Pfüller K; Pfüller U
Arzneimittelforschung; 2004; 54(4):242-9. PubMed ID: 15146937
[TBL] [Abstract][Full Text] [Related]
9. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic effects of the components in heat-treated mistletoe (Viscum album).
Park JH; Hyun CK; Shin HK
Cancer Lett; 1999 May; 139(2):207-13. PubMed ID: 10395180
[TBL] [Abstract][Full Text] [Related]
11. Detection of isolated mistletoe lectin chains in plant extracts.
Tonevitsky AG; Marx U; Agapov I; Moisenovich M
Arzneimittelforschung; 2002; 52(1):67-71. PubMed ID: 11838276
[TBL] [Abstract][Full Text] [Related]
12. Human cancer cells exhibit in vitro individual receptiveness towards different mistletoe extracts.
Knöpfl-Sidler F; Viviani A; Rist L; Hensel A
Pharmazie; 2005 Jun; 60(6):448-54. PubMed ID: 15997835
[TBL] [Abstract][Full Text] [Related]
13. Cytokine release of whole blood from adult female donors challenged with mistletoe lectin-1 standardised mistletoe extract and E. coli endotoxin or phytohaemagglutinin (PHA).
Braun JM; Blackwell CC; Weir DM; Beuth J
Anticancer Res; 2003; 23(2B):1349-52. PubMed ID: 12820393
[TBL] [Abstract][Full Text] [Related]
14. Viscotoxin-free aqueous extracts from European mistletoe (Viscum album L.) stimulate activity of human granulocytes.
Stein GM; Pfüller U; Schietzel M
Anticancer Res; 1999; 19(4B):2925-8. PubMed ID: 10652574
[TBL] [Abstract][Full Text] [Related]
15. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
Franz H
Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
[No Abstract] [Full Text] [Related]
16. Stimulation of cytokine production via a special standardized mistletoe preparation in an in vitro human skin bioassay.
Joller PW; Menrad JM; Schwarz T; Pfüller U; Parnham MJ; Weyhenmeyer R; Lentzen H
Arzneimittelforschung; 1996 Jun; 46(6):649-53. PubMed ID: 8767360
[TBL] [Abstract][Full Text] [Related]
17. Expression of mitochondrial Apo2.7 molecules and caspase-3 activation in human lymphocytes treated with the ribosome-inhibiting mistletoe lectins and the cell membrane permeabilizing viscotoxins.
Büssing A; Vervecken W; Wagner M; Wagner B; Pfüller U; Schietzel M
Cytometry; 1999 Oct; 37(2):133-9. PubMed ID: 10486525
[TBL] [Abstract][Full Text] [Related]
18. Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro.
Thies A; Nugel D; Pfüller U; Moll I; Schumacher U
Toxicology; 2005 Feb; 207(1):105-16. PubMed ID: 15590126
[TBL] [Abstract][Full Text] [Related]
19. Activation of dendritic cells by an aqueous mistletoe extract and mistletoe lectin-3 in vitro.
Stein GM; Büssing A; Schietzel M
Anticancer Res; 2002; 22(1A):267-74. PubMed ID: 12017301
[TBL] [Abstract][Full Text] [Related]
20. Mistletoe lectins: telomerase inhibitors in alternative cancer therapy.
Li SS
Drug Discov Today; 2002 Sep; 7(17):896-7. PubMed ID: 12546929
[No Abstract] [Full Text] [Related]
[Next] [New Search]
